Pozavarovalnica Sava, d.d. (LJSE:POSR)
87.00
+3.00 (3.57%)
At close: Apr 8, 2026
LJSE:POSR Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 893.61 | 801.21 | 697.56 | 608.99 | 686.57 |
Total Interest & Dividend Income | 94.2 | 22.1 | 16.41 | 0.3 | 34.06 |
Gain (Loss) on Sale of Investments | -4.15 | 0.74 | -0.48 | -0.08 | 68.56 |
Other Revenue | -70.47 | - | - | - | 41.48 |
| 940.73 | 847.72 | 733.08 | 627.2 | 830.66 | |
Revenue Growth (YoY) | 10.97% | 15.64% | 16.88% | -24.50% | 21.41% |
Policy Benefits | 741.38 | 477.67 | 424.52 | 367.88 | 500.28 |
Policy Acquisition & Underwriting Costs | - | - | - | - | 79.61 |
Selling, General & Administrative | 37.11 | 246.02 | 219 | 192.01 | - |
Other Operating Expenses | 13.11 | 12.2 | 9.59 | 6.69 | 151.88 |
Total Operating Expenses | 791.6 | 735.89 | 653.1 | 566.58 | 731.77 |
Operating Income | 149.13 | 111.83 | 79.98 | 60.61 | 98.89 |
Interest Expense | -6.02 | -3.97 | -3.11 | -3.02 | -3.13 |
Earnings From Equity Investments | 0.94 | 1.78 | 2.17 | 1.29 | - |
Currency Exchange Gain (Loss) | - | -0.35 | -0 | -0.46 | - |
Other Non Operating Income (Expenses) | - | - | - | - | -2.42 |
EBT Excluding Unusual Items | 144.05 | 109.29 | 79.03 | 58.42 | 93.34 |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.19 |
Asset Writedown | -0.09 | 0.07 | 0.23 | 0.08 | - |
Pretax Income | 143.96 | 109.36 | 79.26 | 58.5 | 93.54 |
Income Tax Expense | 29.92 | 21.96 | 14.96 | 11.58 | 17.37 |
Earnings From Continuing Ops. | 114.04 | 87.41 | 64.3 | 46.92 | 76.17 |
Earnings From Discontinued Ops. | 0.01 | 0.44 | 0.35 | - | - |
Net Income to Company | 114.05 | 87.85 | 64.66 | 46.92 | 76.17 |
Minority Interest in Earnings | -0.14 | -0.19 | -0.19 | -0.23 | -0.09 |
Net Income | 113.91 | 87.66 | 64.46 | 46.7 | 76.07 |
Net Income to Common | 113.91 | 87.66 | 64.46 | 46.7 | 76.07 |
Net Income Growth | 29.95% | 35.98% | 38.05% | -38.62% | 35.31% |
Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 15 |
Shares Outstanding (Diluted) | 15 | 15 | 15 | 15 | 15 |
Shares Change (YoY) | -0.01% | - | - | - | - |
EPS (Basic) | 7.35 | 5.66 | 4.16 | 3.01 | 4.91 |
EPS (Diluted) | 7.35 | 5.66 | 4.16 | 3.01 | 4.91 |
EPS Growth | 29.96% | 35.98% | 38.05% | -38.62% | 35.31% |
Free Cash Flow | 165.23 | 147.24 | 93.46 | 47.8 | 109.77 |
Free Cash Flow Per Share | 10.66 | 9.50 | 6.03 | 3.08 | 7.08 |
Dividend Per Share | - | 2.250 | 1.750 | 1.600 | 1.500 |
Dividend Growth | - | 28.57% | 9.38% | 6.67% | 76.47% |
Operating Margin | 15.85% | 13.19% | 10.91% | 9.66% | 11.91% |
Profit Margin | 12.11% | 10.34% | 8.79% | 7.45% | 9.16% |
Free Cash Flow Margin | 17.56% | 17.37% | 12.75% | 7.62% | 13.21% |
EBITDA | 160.32 | 118.41 | 86.44 | 66.12 | 105.82 |
EBITDA Margin | 17.04% | 13.97% | 11.79% | 10.54% | 12.74% |
D&A For EBITDA | 11.19 | 6.58 | 6.46 | 5.51 | 6.93 |
EBIT | 149.13 | 111.83 | 79.98 | 60.61 | 98.89 |
EBIT Margin | 15.85% | 13.19% | 10.91% | 9.66% | 11.91% |
Effective Tax Rate | 20.78% | 20.08% | 18.87% | 19.79% | 18.57% |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.